|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 51/10 | |
| A61K 51/00 | |||
| A61K 39/395 | |||
| A61K 31/427 | |||
| A61K 31/7036 | |||
| C07K 16/28 | |||
| A61K 39/00 | |||
| A61M 5/14 | |||
| A61K 47/68 | |||
| A61P 35/02 | |||
| A61B 6/00 | |||
| A61K 9/00 | |||
| A61K 101/02 |
| (11) | Number of the document | 3297684 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16797365.0 |
| Date of filing the European patent application | 2016-05-20 | |
| (97) | Date of publication of the European application | 2018-03-28 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/033479 |
| Date | 2016-05-20 |
| (87) | Number | WO 2016/187514 |
| Date | 2016-11-24 |
| (30) | Number | Date | Country code |
| 201562164601 P | 2015-05-21 | US |
| (72) |
DAVE, Kaushik, J., US
ZHANG, Yulian, US
|
| (73) |
Actinium Pharmaceuticals, Inc.,
275 Madison Avenue, 7th Floor, New York, NY 10016,
US
|
| (54) | INFUSION ADMINISTRATION OF CONJUGATED MONOCLONAL ANTIBODIES |
| INFUSION ADMINISTRATION OF CONJUGATED MONOCLONAL ANTIBODIES |